UltraTech Cement sees target cuts, hikes after Q2 results
In short
UltraTech Cement’s Q2FY27 results led Nomura, Citi and Jefferies to change their target prices for the stock. The company reported quarterly profit of Rs 1,494 crore, up 21% year on year, and all three brokerages kept Buy ratings.
This matters because broker calls can move the share price. What the market does next is not stated in the available reporting.
What the reporting says
UltraTech Cement’s Q2FY27 results prompted Nomura, Citi and Jefferies to revise their target prices for the stock. The publisher summary says Nomura and Citi cut targets while Jefferies raised its estimate, and all three kept Buy ratings. UltraTech also reported a 21% year-on-year rise in quarterly profit to Rs 1,494 crore. The immediate market impact is mixed broker sentiment; the longer-term view remains unclear.
Why it matters
UltraTech Cement’s Q2FY27 results led Nomura, Citi and Jefferies to adjust their price targets for the stock. The publisher summary says Nomura and Citi lowered targets, while Jefferies raised its estimate, and all three maintained Buy ratings. UltraTech also reported quarterly profit of Rs 1,494 crore, up 21% year on year. The reporting does not say how investors traded the stock after the revisions.